Quick answer
What is Thymalin?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
Thymalin is a peptide, grouped on this site under Short peptide bioregulators, and the 12 research records kept here are 5 from studies in rats or mice and 7 that do not state what kind of study it is.
The literature search returned 243 records. This site keeps 12 of them, which is 4.9 per cent of what came back.
What it is
This site puts it in the Short peptide bioregulators group.
A thymic polypeptide extract whose constituent KE and EW dipeptides are reported in the retrieved 2023 record to act on gene expression and protein synthesis; immune cell differentiation endpoints are reported elsewhere in the set.[1, 2]
Stated in the titles of the cited 2023 International Journal of Molecular Sciences and 2020 Bulletin of Experimental Biology and Medicine papers.
What kind of records
No public chemistry record was found under this name, so the entry describes a preparation, a protein or a mixture rather than one defined molecule.
That sentence is produced by counting, not by reading. What was counted: PubChem returned no compound record for this name, so the subject is a preparation, protein or mixture rather than a defined small molecule; identity fields are unsourced.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 231 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. International journal of molecular sciences (2023). pmid:37686182
- Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bulletin of experimental biology and medicine (2020). pmid:33237528